Skip to main content
. 2021 Feb 19;10(2):233. doi: 10.3390/pathogens10020233

Figure 3.

Figure 3

Virucidal activity of OSCN and OSCN/LF against SARS-CoV-2. SARS-CoV-2 was diluted in MEM and incubated for 1 h at 37 °C with only OSCN or supplemented with LF before infection of Vero-E6 cells. The reduction of infectivity was evaluated by plaque assay. (a) Virucidal effect of OSCN; (b) comparison between different times of virus-OSCN exposure on the efficiency of the virucidal activity; (c) evaluation of the combination OSCN+ LF on the virucidal activity. Data (mean ± SD, N = 3, experiments in duplicate) are percentages of no drug, set as 100%.